DelfaGLP-1 Atlas

Lead sponsor

University of Florida

3 GLP-1 and incretin trials led. Source: ClinicalTrials.gov, as of July 1, 2026.

3

Trials led

1

Active

49

Total enrollment

3

Sites

Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.

Portfolio

How this sponsor's trials break down

Trials by phase

Phase 1
1
Phase 2
1
Phase 4
1

Trials by status

Recruiting
1
Completed
2

Trials led

Adding Exenatide to Insulin Therapy for Patients With Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease—Ph 4Completed24
A Study to Estimate Early Clinical Efficacy Signals of GLP-1 Agonist Administration in Conjunction With Levonorgestrel Intrauterine Device in Obese Patients With Endometrioid Intraepithelial NeoplasiaBMI ≥30Ph 2Recruiting20
Effects of Exenatide on Motor Function and the Brain—Ph 1Completed5